Improved Accuracy and Reliability in Untargeted Analysis with LC-ESI-QTOF/MS¹ by Ensemble Averaging by Guillaume Laurent Erny (21000926)

Subjects:

Improvement of SPPF to SPPF-R process. by Pingping Yan (462509)

“…Furthermore, Parameters and GFLOPs were reduced by 10.0% and 23.2%, respectively, indicating a significant enhancement in detection accuracy along with a substantial decrease in both parameters and computational costs. …”

a-d. Difference in (a) probing depth; (b) clinical attachment level; (c) bleeding on probing, and (d) plaque index values between baseline and six months after treatment using syst... by Iva Milinkovic (22331710)

Subjects:

Detecting neural spikes by thresholding. by Ariel Burman (20329776)

Subjects:

Dynamical changes in the buffer population (<i>L</i> = 1023). by Ariel Burman (20329776)

Subjects:

Hardware implementation. by Ariel Burman (20329776)

Subjects:

Median estimates of an extracellular recording. by Ariel Burman (20329776)

Subjects:

Comparison of estimator performance across various input distributions. by Ariel Burman (20329776)

Subjects:

Hardware comparison. by Ariel Burman (20329776)

Subjects:

Sudden change from skewed distributions. by Ariel Burman (20329776)

Subjects:

Estimator robustness against extreme outliers. by Ariel Burman (20329776)

Subjects:

Sensitivity to small changes. by Ariel Burman (20329776)

Subjects:

Settling time for changes in the median of the Folded Normal distribution. by Ariel Burman (20329776)

Subjects:

Time and spatial sensitivity to process changes. by Ariel Burman (20329776)

Subjects:

Microflow Liquid Chromatography Coupled to Multinozzle Electrospray Ionization for Improved Lipidomics Coverage of 3D Clear Cell Renal Cell Carcinoma by Sergey Girel (6887840)

Subjects:

Segmented regression analysis of time to intravenous antimicrobial administration (IVA) at intervention and control sites during the implementation period. by J Mark Ansermino (13958512)

Subjects:

Interrupted time series analysis showing time to intravenous antimicrobials (IVA) in minutes at intervention and control sites in Uganda during baseline and implementation periods. by J Mark Ansermino (13958512)

Subjects:

Kenya: Enrolment, time to IVA, mortality, admissions and readmissions at sites in Kenya. by J Mark Ansermino (13958512)

Subjects:

Uganda: enrolment, time to IVA, mortality, admissions and readmissions. by J Mark Ansermino (13958512)

Subjects:

Interrupted time series analysis showing time to intravenous antimicrobials (IVA) in minutes at intervention and control sites in Kenya during baseline and implementation periods. by J Mark Ansermino (13958512)

Subjects: